Peptides including a binding domain of the viral phosphoprotein (p) subunit to the viral rna free nucleoprotein (n0)
WO2016001754A2
Methods for three dimensional reconstruction and determining the quality of an embryo
EP3060221A1
Methods and pharmaceutical composition for the treatment of polyomavirus infections
EP3049534A2
Methods and kits for diagnosing ulcerative colitis in a subject
EP3027648A1
Anti-claudin 1 antibodies and uses thereof
EP3027207A1
Anti-claudin 1 antibodies for use in the treatment of colorectal cancer
EP3019885A1
Shear wave imaging method and installation for collecting information on a soft solid
EP3004165A1
Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomas
EP2986287A2
Methods and pharmaceutical compositions (ctps 1 inhibitors, e.g. norleucine) for inhibiting t cell proliferation in a subject in need thereof
EP2978774A1
Methods and pharmaceuticals compositions for treating breast cancers
EP2929346A1
Diagnosis of cystic fibrosis
EP2911681A1
Lyve-1 antagonists for preventing or treating a pathological condition associated with lymphangiogenesis
EP2909333A1
Methods for predicting and treating bone metastases in prostate cancer patients
EP2872888A1
Methods for determining whether a cytomegalovirus infection in a transplanted patient is suceptible to induce allograft rejection
EP2880449A1
Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
EP2846793A1
Methods and pharmaceutical compositions for prevention or treatment of chronic obstructive pulmonary disease
EP2807181A1
Vaccine compositions for hiv prevention and treatment
EP2776130A1
A ddr1 antagonist or an inhibitor of ddr1 gene expression for use in the prevention or treatment of crescentic glomerulonephritis
EP2736502A1
Method for increasing the intraocular pressure in an animal
